• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

I just made it up as I went along





Hello This rep I knew had a great sense of humor. Maybe he wasn’t the best rep, but he was competent and helpful. He was eccentric, certainly, the opposite of his 5 pod members who are a straight shooter. It’s a shame that he got scooped up in the tsunami of lies. The public will only think of him as a crazy rep,but I have mostly fond memories of him. RIP Mr rep Condolences to family, friends, and 5 pod members.
I just got a new position so at noon today right hear I’m announcing my departures.

STAY TUNED